Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study
Claus Garbe, Nicole Basset‐Séguin, Yves Poulin, et al.
British Journal of Dermatology (2015) Vol. 174, Iss. 3, pp. 505-513
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives
Rafael C. Dutra, Maria M. Campos, Adair R.S. Santos, et al.
Pharmacological Research (2016) Vol. 112, pp. 4-29
Closed Access | Times Cited: 403
British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis 2017
D. de Berker, J.M. McGregor, M.F. Mohd Mustapa, et al.
British Journal of Dermatology (2017) Vol. 176, Iss. 1, pp. 20-43
Open Access | Times Cited: 193
Guidelines of care for the management of actinic keratosis
Daniel B. Eisen, Maryam M. Asgari, Daniel Bennett, et al.
Journal of the American Academy of Dermatology (2021) Vol. 85, Iss. 4, pp. e209-e233
Open Access | Times Cited: 122
Actinic keratosis – review for clinical practice
Erika C. V. de Oliveira, Valéria R. V. da Motta, Paola C. Pantoja, et al.
International Journal of Dermatology (2018) Vol. 58, Iss. 4, pp. 400-407
Closed Access | Times Cited: 81
Field cancerization: Treatment
Christine Cornejo, Anokhi Jambusaria‐Pahlajani, Tyler J. Willenbrink, et al.
Journal of the American Academy of Dermatology (2020) Vol. 83, Iss. 3, pp. 719-730
Closed Access | Times Cited: 56
Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review
Nathan Jetter, Neha Chandan, Stephanie Wang, et al.
American Journal of Clinical Dermatology (2018) Vol. 19, Iss. 4, pp. 543-557
Closed Access | Times Cited: 55
Actinic Keratosis and Cutaneous Squamous Cell Carcinoma
Ralf Gutzmer, Susanne Wiegand, Oliver Kölbl, et al.
Deutsches Ärzteblatt international (2019)
Open Access | Times Cited: 37
Treatment considerations in actinic keratosis
Gary Goldenberg
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. S2, pp. 12-16
Open Access | Times Cited: 37
Non‐invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques
Cristel Ruini, Daniela Hartmann, Mike Bastian, et al.
Journal of Biophotonics (2019) Vol. 12, Iss. 7
Closed Access | Times Cited: 20
Guidelines of care for the management of actinic keratosis: Executive summary
Daniel B. Eisen, Maryam M. Asgari, Daniel Bennett, et al.
Journal of the American Academy of Dermatology (2021) Vol. 85, Iss. 4, pp. 945-955
Closed Access | Times Cited: 16
German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023
Ulrike Leiter, Markus V. Heppt, Theresa Steeb, et al.
EJC Skin Cancer (2023) Vol. 1, pp. 100004-100004
Open Access | Times Cited: 4
Analysis of apoptosis‐associated molecules Erythroid differentiation regulator 1, bcl‐2 and p53 in actinic keratosis after treatment with ingenol mebutate
Yu Ri Woo, Ji Hong Lim, Seo-Won Jeong, et al.
Experimental Dermatology (2017) Vol. 26, Iss. 11, pp. 1012-1017
Closed Access | Times Cited: 11
Aktinische Keratosen
Theresa Hommel, Rolf‐Markus Szeimies
Der Hautarzt (2016) Vol. 67, Iss. 11, pp. 867-875
Closed Access | Times Cited: 10
Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis
Eggert Stockfleth, Mike Bastian
Expert Opinion on Drug Metabolism & Toxicology (2018) Vol. 14, Iss. 9, pp. 911-918
Closed Access | Times Cited: 11
Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series
Ivan Bobyr, Anna Campanati, Veronica Consales, et al.
SpringerPlus (2016) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Cost-effectiveness of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis in Greece
Kostas Athanasakis, N. Boubouchairopoulou, F Tarantilis, et al.
Clinical Therapeutics (2017) Vol. 39, Iss. 5, pp. 993-1002
Closed Access | Times Cited: 9
Evaluation of the costs of topical treatments for actinic keratosis based on lesion response and the affected area
Piergiacomo Calzavara‐Pinton, Cristina Zane, Mariachiara Arisi, et al.
Giornale Italiano di Dermatologia e Venereologia (2018) Vol. 153, Iss. 6
Closed Access | Times Cited: 9
Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
Nevena Skroza, Ilaria Proietti, Nicoletta Bernardini, et al.
World Journal of Clinical Oncology (2017) Vol. 8, Iss. 5, pp. 405-411
Open Access | Times Cited: 8
Ingenol mebutate for the treatment of actinic keratosis: effectiveness and safety in 246 patients treated in real-life clinical practice
Rosa Ortega del Olmo, Rafael Salido‐Vallejo
Journal of Dermatological Treatment (2017) Vol. 29, Iss. 4, pp. 393-399
Open Access | Times Cited: 7
Field cancerization therapy with ingenol mebutate contributes to restoring skin-metabolism to normal-state in patients with actinic keratosis: a metabolomic analysis
Valeria Righi, Elisabetta Tarentini, Adele Mucci, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Noninvasive Long-term Monitoring of Actinic Keratosis and Field Cancerization Following Treatment with Ingenol Mebutate Gel 0.015.
Orit Markowitz, Katie Wang, Amanda Levine, et al.
PubMed (2017) Vol. 10, Iss. 10, pp. 28-33
Closed Access | Times Cited: 5
Topical agents for preventing and treating actinic keratosis
Steve Chaplin
Prescriber (2016) Vol. 27, Iss. 4, pp. 32-40
Closed Access | Times Cited: 4
Ingenol mebutate‐mediated reduction in p53‐positive keratinocytes in skin cancerization field directly correlates with clinical response in patients with multiple actinic keratoses
Vieri Grandi, Paola Di Gennaro, S. Torrigiani, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 33, Iss. 7, pp. 1297-1303
Closed Access | Times Cited: 4
Ingenol mebutate for actinic keratosis: a field-directed therapy with short duration
Marjan Garmyn
British Journal of Dermatology (2016) Vol. 174, Iss. 3, pp. 481-482
Closed Access | Times Cited: 3
Treatment of Actinic Keratosis: The Best Choice through an Observational Study
Seung Ah Yoo, Yeong Ho Kim, Ju Hee Han, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 3953-3953
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top